Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Recruiting

Emicizumab vs. Factor VIIIPrevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

Sponsor:

Wayne State University

Code:

NCT05022459

Conditions

Hemophilia A

Eligibility Criteria

Sex: All

Age: 6 - 19

Healthy Volunteers: Not accepted

Interventions

Emicizumab

FVIII

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-24. This information was provided to ClinicalTrials.gov by Wayne State University on 2026-01-16.